SMTL ID : 5ycn.1

Human PPARgamma ligand binding domain complexed with Lobeglitazone

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.15 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 8LX: (5S)-5-[[4-[2-[[6-(4-methoxyphenoxy)pyrimidin-4-yl]-methyl-amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione(Non-covalent)

8LX.1: 18 residues within 4Å: Chain A: L.61, R.86, I.87, F.88, G.90, C.91, S.95, H.129, Y.133, L.136, V.145, I.147, M.154, M.170, H.255, L.259, L.275, Y.279 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.61, A:I.147 Hydrogen bonds: A:R.86, A:S.95, A:Y.279, A:Y.279 Water bridges: A:R.94, A:S.148

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jang, J.Y. et al., Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPAR gamma. Sci Rep (2018)

Release Date

2018-09-12

Peptides

Peroxisome proliferator-activated receptor gamma: A
Nuclear receptor coactivator 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Peroxisome proliferator-activated receptor gamma

Nuclear receptor coactivator 1

Related Entries With Identical Sequence